[1]
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20:120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5
[PubMed PMID: 19805654]
[2]
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Current hypertension reports. 2018 Feb 26:20(2):12. doi: 10.1007/s11906-018-0812-z. Epub 2018 Feb 26
[PubMed PMID: 29480368]
[3]
Samson SL, Garber AJ. Metabolic syndrome. Endocrinology and metabolism clinics of North America. 2014 Mar:43(1):1-23. doi: 10.1016/j.ecl.2013.09.009. Epub
[PubMed PMID: 24582089]
[4]
Kazemi T, Sharifzadeh G, Zarban A, Fesharakinia A. Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study. International journal of preventive medicine. 2013 Jan:4(1):110-4
[PubMed PMID: 23411742]
Level 3 (low-level) evidence
[5]
Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacological research. 2017 Jun:120():34-42. doi: 10.1016/j.phrs.2017.03.008. Epub 2017 Mar 12
[PubMed PMID: 28300617]
[6]
Caballero B. Humans against Obesity: Who Will Win? Advances in nutrition (Bethesda, Md.). 2019 Jan 1:10(suppl_1):S4-S9. doi: 10.1093/advances/nmy055. Epub
[PubMed PMID: 30721956]
Level 3 (low-level) evidence
[7]
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. The Journal of clinical investigation. 2017 Jan 3:127(1):1-4. doi: 10.1172/JCI92035. Epub 2017 Jan 3
[PubMed PMID: 28045402]
[8]
Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Journal of atherosclerosis and thrombosis. 2011:18(8):629-39
[PubMed PMID: 21737960]
[9]
Handelsman Y. Metabolic syndrome pathophysiology and clinical presentation. Toxicologic pathology. 2009 Jan:37(1):18-20. doi: 10.1177/0192623308329288. Epub 2008 Dec 19
[PubMed PMID: 19098117]
[10]
van der Pal KC, Koopman ADM, Lakerveld J, van der Heijden AA, Elders PJ, Beulens JW, Rutters F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep medicine. 2018 Dec:52():51-57. doi: 10.1016/j.sleep.2018.07.022. Epub 2018 Aug 22
[PubMed PMID: 30278295]
[11]
Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk factors in adults with intellectual disabilities. Journal of exercise rehabilitation. 2018 Aug:14(4):592-597. doi: 10.12965/jer.1836302.151. Epub 2018 Aug 24
[PubMed PMID: 30276179]
[12]
Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of Metabolic Syndrome and Dietary Intervention. International journal of molecular sciences. 2018 Dec 31:20(1):. doi: 10.3390/ijms20010128. Epub 2018 Dec 31
[PubMed PMID: 30602666]
[13]
Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D, Isenovic ER. Link between Metabolic Syndrome and Insulin Resistance. Current vascular pharmacology. 2017:15(1):30-39
[PubMed PMID: 27748199]
[14]
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International journal of molecular sciences. 2022 Jan 12:23(2):. doi: 10.3390/ijms23020786. Epub 2022 Jan 12
[PubMed PMID: 35054972]
[15]
Cho DH, Kim MN, Joo HJ, Shim WJ, Lim DS, Park SM. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2019 Apr:29(4):360-366. doi: 10.1016/j.numecd.2019.01.007. Epub 2019 Jan 29
[PubMed PMID: 30782509]
[16]
Ferguson-Smith AC, Patti ME. You are what your dad ate. Cell metabolism. 2011 Feb 2:13(2):115-7. doi: 10.1016/j.cmet.2011.01.011. Epub
[PubMed PMID: 21284975]
[17]
Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proceedings of the National Academy of Sciences of the United States of America. 2008 Nov 4:105(44):17046-9. doi: 10.1073/pnas.0806560105. Epub 2008 Oct 27
[PubMed PMID: 18955703]
[18]
Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. International journal of obesity (2005). 2011 Mar:35(3):393-400. doi: 10.1038/ijo.2010.152. Epub 2010 Aug 3
[PubMed PMID: 20680014]
[20]
Lovre D, Mauvais-Jarvis F. Trends in Prevalence of the Metabolic Syndrome. JAMA. 2015 Sep 1:314(9):950. doi: 10.1001/jama.2015.8625. Epub
[PubMed PMID: 26325567]
[21]
Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Mañas LR, Mattace Raso FU, Muiesan ML, Ryliškytė L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM, Metabolic Syndrome and Arteries Research (MARE) Consortium. Metabolic syndrome across Europe: different clusters of risk factors. European journal of preventive cardiology. 2015 Apr:22(4):486-91. doi: 10.1177/2047487314525529. Epub 2014 Mar 19
[PubMed PMID: 24647805]
[22]
Cleven L, Krell-Roesch J, Schmidt SCE, Dziuba A, Bös K, Jekauc D, Woll A. Longitudinal association between physical activity and the risk of incident metabolic syndrome in middle-aged adults in Germany. Scientific reports. 2022 Nov 12:12(1):19424. doi: 10.1038/s41598-022-24052-5. Epub 2022 Nov 12
[PubMed PMID: 36371479]
[23]
Szypowska A, Zatońska K, Szuba A, Regulska-Ilow B. Dietary Inflammatory Index (DII)(®) and Metabolic Syndrome in the Selected Population of Polish Adults: Results of the PURE Poland Sub-Study. International journal of environmental research and public health. 2023 Jan 6:20(2):. doi: 10.3390/ijerph20021056. Epub 2023 Jan 6
[PubMed PMID: 36673811]
[24]
Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. International journal of obesity (2005). 2007 Jan:31(1):177-88
[PubMed PMID: 16652128]
[25]
Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, Tounouga DN, Tianyi FL, Foka AJ, Ndoadoumgue AL, Bigna JJ. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. The Lancet. Child & adolescent health. 2022 Mar:6(3):158-170. doi: 10.1016/S2352-4642(21)00374-6. Epub 2022 Jan 17
[PubMed PMID: 35051409]
Level 1 (high-level) evidence
[26]
Grundy SM. Metabolic syndrome pandemic. Arteriosclerosis, thrombosis, and vascular biology. 2008 Apr:28(4):629-36. doi: 10.1161/ATVBAHA.107.151092. Epub 2008 Jan 3
[PubMed PMID: 18174459]
[27]
Guess J, Beltran TH, Choi YS. Prediction of Metabolic Syndrome in U.S. Adults Using Homeostasis Model Assessment-Insulin Resistance. Metabolic syndrome and related disorders. 2023 Apr:21(3):156-162. doi: 10.1089/met.2022.0097. Epub 2023 Feb 14
[PubMed PMID: 36787450]
[28]
Camera A, Hopps E, Caimi G. [Metabolic syndrome: from insulin resistance to adipose tissue dysfunction]. Minerva medica. 2008 Jun:99(3):307-21
[PubMed PMID: 18497727]
[29]
Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. The Medical clinics of North America. 2007 Nov:91(6):1063-77, viii
[PubMed PMID: 17964909]
[30]
Lann D, Gallagher E, Leroith D. Insulin resistance and the metabolic syndrome. Minerva medica. 2008 Jun:99(3):253-62
[PubMed PMID: 18497723]
[31]
Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic advances in cardiovascular disease. 2017 Aug:11(8):215-225. doi: 10.1177/1753944717711379. Epub 2017 Jun 22
[PubMed PMID: 28639538]
Level 3 (low-level) evidence
[32]
Park SE, Rhee EJ, Lee WY, Kim WJ, Yoo SH, Bae JC, Choi ES, Park CY, Oh KW, Park SW, Kim SW. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2012 Jun:22(6):525-32. doi: 10.1016/j.numecd.2010.09.008. Epub 2010 Dec 24
[PubMed PMID: 21186114]
[33]
Manoharan MP, Raja R, Jamil A, Csendes D, Gutlapalli SD, Prakash K, Swarnakari KM, Bai M, Desai DM, Desai A, Penumetcha SS. Obesity and Coronary Artery Disease: An Updated Systematic Review 2022. Cureus. 2022 Sep:14(9):e29480. doi: 10.7759/cureus.29480. Epub 2022 Sep 23
[PubMed PMID: 36299943]
Level 1 (high-level) evidence
[34]
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proceedings of the National Academy of Sciences of the United States of America. 1994 May 24:91(11):4854-8
[PubMed PMID: 8197147]
[35]
Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, Thuren T, CANTOS Pilot Investigative Group. Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012 Dec 4:126(23):2739-48. doi: 10.1161/CIRCULATIONAHA.112.122556. Epub 2012 Nov 5
[PubMed PMID: 23129601]
Level 1 (high-level) evidence
[36]
Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. Journal of the American Society of Nephrology : JASN. 2004 Nov:15(11):2792-800
[PubMed PMID: 15504932]
[37]
He Y, Wu W, Wu S, Zheng HM, Li P, Sheng HF, Chen MX, Chen ZH, Ji GY, Zheng ZD, Mujagond P, Chen XJ, Rong ZH, Chen P, Lyu LY, Wang X, Xu JB, Wu CB, Yu N, Xu YJ, Yin J, Raes J, Ma WJ, Zhou HW. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome. 2018 Sep 24:6(1):172. doi: 10.1186/s40168-018-0557-6. Epub 2018 Sep 24
[PubMed PMID: 30249275]
[38]
Cӑtoi AF, Pârvu AE, Andreicuț AD, Mironiuc A, Crӑciun A, Cӑtoi C, Pop ID. Metabolically Healthy versus Unhealthy Morbidly Obese: Chronic Inflammation, Nitro-Oxidative Stress, and Insulin Resistance. Nutrients. 2018 Sep 1:10(9):. doi: 10.3390/nu10091199. Epub 2018 Sep 1
[PubMed PMID: 30200422]
[39]
Giannopoulos CK, Tzima IG, Tentolouris NK, Vasileiadis IA. Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Current diabetes reviews. 2023:19(9):e160223213720. doi: 10.2174/1573399819666230216112032. Epub
[PubMed PMID: 36797616]
[40]
Huang PL. A comprehensive definition for metabolic syndrome. Disease models & mechanisms. 2009 May-Jun:2(5-6):231-7. doi: 10.1242/dmm.001180. Epub
[PubMed PMID: 19407331]
[41]
Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Acanthosis Nigricans: An Updated Review. Current pediatric reviews. 2022:19(1):68-82. doi: 10.2174/1573396318666220429085231. Epub
[PubMed PMID: 36698243]
[42]
Khatiwada S, Sah SK, Kc R, Baral N, Lamsal M. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome. Clinical diabetes and endocrinology. 2016:2():3. doi: 10.1186/s40842-016-0021-0. Epub 2016 Feb 1
[PubMed PMID: 28702239]
[43]
Puig JG, Martínez MA. Hyperuricemia, gout and the metabolic syndrome. Current opinion in rheumatology. 2008 Mar:20(2):187-91. doi: 10.1097/BOR.0b013e3282f4b1ed. Epub
[PubMed PMID: 18349749]
Level 3 (low-level) evidence
[44]
Bittner V. The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2020 Dec 22:142(25):2402-2404. doi: 10.1161/CIRCULATIONAHA.119.040625. Epub 2019 Mar 17
[PubMed PMID: 30879338]
[45]
Dzaye O, Dudum R, Reiter-Brennan C, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M, Blaha MJ. Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines. Progress in cardiovascular diseases. 2019 Sep-Oct:62(5):423-430. doi: 10.1016/j.pcad.2019.10.007. Epub 2019 Nov 9
[PubMed PMID: 31715194]
[46]
Klimova B, Kuca K, Maresova P. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus. Current Alzheimer research. 2018:15(14):1277-1282. doi: 10.2174/1567205015666180925110222. Epub
[PubMed PMID: 30251605]
[47]
Chiarelli F, Mohn A. Early diagnosis of metabolic syndrome in children. The Lancet. Child & adolescent health. 2017 Oct:1(2):86-88. doi: 10.1016/S2352-4642(17)30043-3. Epub 2017 Aug 24
[PubMed PMID: 30169210]
[48]
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic medicine : a journal of the British Diabetic Association. 2006 May:23(5):469-80
[PubMed PMID: 16681555]
Level 3 (low-level) evidence
[49]
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019 Sep 10:74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17
[PubMed PMID: 30894318]
Level 1 (high-level) evidence
[50]
Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014 Jul 1:63(25 Pt B):2960-84. doi: 10.1016/j.jacc.2013.11.003. Epub 2013 Nov 12
[PubMed PMID: 24239922]
Level 1 (high-level) evidence
[51]
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18:139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10
[PubMed PMID: 30586774]
Level 1 (high-level) evidence
[52]
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2018 May 15:71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13
[PubMed PMID: 29146535]
Level 1 (high-level) evidence
[53]
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I, List of authors/Task Force members:. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. Journal of hypertension. 2018 Dec:36(12):2284-2309. doi: 10.1097/HJH.0000000000001961. Epub
[PubMed PMID: 30379783]
Level 1 (high-level) evidence
[54]
Herman R, Kravos NA, Jensterle M, Janež A, Dolžan V. Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport. International journal of molecular sciences. 2022 Jan 23:23(3):. doi: 10.3390/ijms23031264. Epub 2022 Jan 23
[PubMed PMID: 35163187]
[55]
Zhong J, Maiseyeu A, Davis SN, Rajagopalan S. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. Circulation research. 2015 Apr 10:116(8):1491-504. doi: 10.1161/CIRCRESAHA.116.305665. Epub
[PubMed PMID: 25858071]
[56]
Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, Nowak A, Madej P. The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome. International journal of molecular sciences. 2022 Apr 14:23(8):. doi: 10.3390/ijms23084334. Epub 2022 Apr 14
[PubMed PMID: 35457152]
[57]
Arozal W, Louisa M, Soetikno V. Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies. Frontiers in cardiovascular medicine. 2020:7():82. doi: 10.3389/fcvm.2020.00082. Epub 2020 May 6
[PubMed PMID: 32435657]
[58]
Cordero P, Li J, Oben JA. Bariatric surgery as a treatment for metabolic syndrome. The journal of the Royal College of Physicians of Edinburgh. 2017 Dec:47(4):364-368. doi: 10.4997/JRCPE.2017.414. Epub
[PubMed PMID: 29537411]
[60]
Gluvic Z, Sudar E, Tica J, Jovanovic A, Zafirovic S, Tomasevic R, Isenovic ER. Effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: a prospective pilot study. International journal of endocrinology. 2015:2015():147070. doi: 10.1155/2015/147070. Epub 2015 Mar 2
[PubMed PMID: 25821465]
Level 3 (low-level) evidence
[61]
Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites. 2021 Dec 14:11(12):. doi: 10.3390/metabo11120869. Epub 2021 Dec 14
[PubMed PMID: 34940628]
[62]
Kaplan NM. The deadly quartet and the insulin resistance syndrome: an historical overview. Hypertension research : official journal of the Japanese Society of Hypertension. 1996 Jun:19 Suppl 1():S9-11
[PubMed PMID: 9240756]
Level 3 (low-level) evidence
[63]
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21:129(3):399-410. doi: 10.1161/01.cir.0000442015.53336.12. Epub
[PubMed PMID: 24446411]
[64]
de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE, Strong Heart Study Investigators. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes care. 2007 Jul:30(7):1851-6
[PubMed PMID: 17440172]
[65]
Russo MP, Grande-Ratti MF, Burgos MA, Molaro AA, Bonella MB. Prevalence of diabetes, epidemiological characteristics and vascular complications. Archivos de cardiologia de Mexico. 2023:93(1):30-36. doi: 10.24875/ACM.21000410. Epub
[PubMed PMID: 36757785]
Level 2 (mid-level) evidence
[66]
Dopp JM, Reichmuth KJ, Morgan BJ. Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management. Current hypertension reports. 2007 Dec:9(6):529-34
[PubMed PMID: 18367017]
[67]
Carson C, Lawson HA. Epigenetics of metabolic syndrome. Physiological genomics. 2018 Nov 1:50(11):947-955. doi: 10.1152/physiolgenomics.00072.2018. Epub 2018 Sep 21
[PubMed PMID: 30240346]
[68]
Albert Pérez E, Mateu Olivares V, Martínez-Espinosa RM, Molina Vila MD, Reig García-Galbis M. New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT. Nutrients. 2018 Jul 6:10(7):. doi: 10.3390/nu10070878. Epub 2018 Jul 6
[PubMed PMID: 29986479]
Level 1 (high-level) evidence
[69]
Cichos KH, Churchill JL, Phillips SG, Watson SL, McGwin G Jr, Ghanem ES, Ponce BA. Metabolic syndrome and hip fracture: Epidemiology and perioperative outcomes. Injury. 2018 Nov:49(11):2036-2041. doi: 10.1016/j.injury.2018.09.012. Epub 2018 Sep 8
[PubMed PMID: 30236796]
[70]
Chen YY, Fang WH, Wang CC, Kao TW, Chang YW, Yang HF, Wu CJ, Sun YS, Chen WL. Association of Percentage Body Fat and Metabolic Health in Offspring of Patients with Cardiovascular Diseases. Scientific reports. 2018 Sep 14:8(1):13831. doi: 10.1038/s41598-018-32230-7. Epub 2018 Sep 14
[PubMed PMID: 30218093]